|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/28 | (2006.01) | ||
| A61K 31/606 | (2006.01) |
| (11) | Number of the document | 3368017 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16787790.1 |
| Date of filing the European patent application | 2016-10-21 | |
| (97) | Date of publication of the European application | 2018-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-06 |
| (46) | Date of publication of the claims translation | 2020-01-27 |
| (86) | Number | PCT/EP2016/075427 |
| Date | 2016-10-21 |
| (87) | Number | WO 2017/072050 |
| Date | 2017-05-04 |
| (30) | Number | Date | Country code |
| 15192269 | 2015-10-30 | EP |
| (72) |
WILHELM, Rudolph, DE
PRÖLS, Markus, DE
GREINWALD, Roland, DE
NACAK, Tanju, DE
|
| (73) |
Dr. Falk Pharma GmbH,
Leinenweberstrasse 5, 79108 Freiburg,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Optimizuota didelės dozės mesalazino tabletė |
| OPTIMIZED HIGH-DOSE TABLET OF MESALAZINE |
| Payment date | Validity (years) | Amount | |
| 2025-10-09 | 10 | 231.00 EUR |
| 2026-10-21 |